Agenus Inc.
ANTI-LAG-3 ANTIBODIES AND METHODS OF USE THEREOF

Last updated:

Abstract:

The instant disclosure provides antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize LAG-3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.

Status:
Application
Type:

Utility

Filling date:

23 Oct 2020

Issue date:

25 Feb 2021